CMS Cuts BRCA Price by 49% in Response to Competition

IN THE FINAL WEEKS OF 2013, the federal Centers for Medicare & Medicaid Services (CMS) announced that it would reduce the price it pays for the BRCA genetic test by 49%, to $1,438, effective on January 1, 2014. For Myriad Genetics, Inc., this was not welcome news. Its share price fell by as much as …

CMS Cuts BRCA Price by 49% in Response to Competition Read More »

To access this post, you must purchase The Dark Report.

CMS Cuts BRCA Price by 49% in Response to Competition

Federal agency uses gap-fill procedure and reduces payment for BRCA genetic test to $1,438

Comments

TABLE OF CONTENTS

Need A Group Membership? Company Discounts are Available!

You are reading premium content from The Dark Report, your primary resource for running an efficient and profitable laboratory.

Get Unlimited Access to The Dark Report absolutely FREE!

You have read 0 of 1 of your complimentary articles this month

You have read 0 of 1 of your complimentary articles this month